It has been proposed that BFT exposure in the human colon may induce chronic IL-17–dependent inflammation, causing epithelial barrier damage and oxidative DNA damage, resulting in increased risk of colorectal carcinoma [25,26,27]. This evidence concerns the gene IL17A and colorectal carcinoma.